BSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹480.00
- Market cap
- ₹18,365 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 172.9×Sector 46.1×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Board Meeting Date
Cohance Lifesciences will hold a board meeting on 6 November 2026 to approve Q2 and half-year results. The trading window stays closed until 9 November 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b), disclosing promoter and public shareholding data as of September 30, 2026.
Cohance Lifesciences Regulatory Approval
Cohance Lifesciences received Central Government approval for the appointment of Mr. Umang Vohra as Chairman and Group CEO.
Cohance Lifesciences Employee Stock Options
Cohance Lifesciences Ltd. approved the grant of 2,60,194 stock options under ESOP 2026 and 6,14,594 stock options under ESOP 2023 to eligible employees.
Cohance Lifesciences Management Change
Cohance Lifesciences appointed Mr. Abhimanyu Ojha as the new Chief Financial Officer and Key Managerial Personnel, effective October 12, 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences received a voluntary ESG Rating of Crisil ESG 61 (Strong) from Crisil ESG Ratings. No capital or business event is involved.
Other other announcement announcements
All →Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM
Kalpataru Other Announcement
Kalpataru filed CARE Ratings' IPO monitoring report for the quarter ended September 30, 2026. It reports no deviation from offer objects, though fund co-mingling was noted.
Rnit AI Solutions Other Announcement
RNIT AI Solutions filed its quarterly Reg 32 statement for the preferential issue. It reports no deviation in use of funds.
Persistent Systems Other Announcement
Persistent Systems filed its shareholding pattern for 26 October 2026, reflecting the increase in paid-up capital from its QIP allotment. The filing shows the post-allotment shareholding split.